SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2126319

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2126319

Ventilators Market by Mobility (Intensive Care Ventilators, Transportable Ventilators), Type (Adult & Pediatric Ventilators), Interface (Invasive Ventilation), Mode (Combined Mode Ventilation), Care Setting (Hospitals & Clinics)- Global Forecast to 2031

PUBLISHED:
PAGES: 294 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

List of Tables

The ventilators market is projected to reach USD 3.10 billion by 2031 from USD 2.49 billion in 2026 at a CAGR of 4.4% during the forecast period.

Scope of the Report
Years Considered for the Study2026-2031
Base Year2025
Forecast Period2026-2031
Units ConsideredValue (USD billion)
SegmentsBy Mobility, Type, Age group, Interface, Mode, Care Setting, and Region
Regions coveredNorth America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa

Increasing respiratory illnesses like COPD and asthma are key drivers of the ventilators market. With growing air pollution levels, lifestyles, and aging populations, an increased number of these chronic ailments have resulted in more frequent and severe respiratory attacks. COPD and severe asthma patients frequently need respiratory support through acute exacerbation, increasing hospital and homecare demand for both invasive and non-invasive ventilators. Further, ongoing advancements in ventilator technology-safety, accuracy, and patient outcomes-prompt healthcare professionals to invest in newer respiratory support equipment. The increasing burden of respiratory illnesses is thus driving market growth.

Ventilators Market - IMG1

The high-end ICU ventilators segment accounts for the largest share of the global ventilators market.

Premium ICU ventilators dominate the global ventilators market because they are crucial for treating life-threatening conditions in intensive care units. These advanced devices offer a wide range of ventilation modes, sophisticated monitoring systems, and enhanced safety features, all of which are essential for critically ill patients. As the global population ages and the incidence of complex respiratory diseases rises, healthcare facilities are increasingly investing in next-generation ICU solutions. Additionally, continuous innovations and stringent regulations from governing bodies support the adoption of these advanced devices, making them the preferred choice for life-critical situations where optimal patient outcomes are important.

Combined mode ventilation has the largest market share in the ventilators market.

Combined mode ventilators hold the largest market share in the ventilator segment because they offer the best features of both volume- and pressure-controlled ventilation. This allows clinicians to tailor respiratory support to meet the individual needs of each patient. These ventilators enable precise control over tidal volumes while ensuring that pressure remains within safe limits to prevent lung injury, making them a versatile solution suitable for a variety of clinical situations.

Additionally, the advanced monitoring systems and automated adjustments of these devices enhance convenience and improve patient outcomes. As a result, combined mode ventilators are highly sought after in intensive care units where critically ill patients require adaptable and flexible ventilation options. Moreover, ongoing technological innovations, increased investments in healthcare facilities, and a rise in respiratory illnesses have all contributed to the growing demand for combined mode ventilators in the market.

Europe holds the second-largest market share in the ventilators market.

Europe is the world's second-largest ventilators market, with its established healthcare infrastructure, heavy government spending, and stringent regulation that guarantees top-quality products. Extensive coverage of intensive care units and hospitals in Europe, combined with a high incidence of respiratory conditions and an aging population, ensures rising demand for invasive and non-invasive ventilators.

Europe benefits from a dynamic community of leading producers and continuous innovation, resulting in the development of advanced technologies that enhance patient outcomes. Coupled with progressive healthcare initiatives and comprehensive insurance coverage, Europe stands out as a significant market for ventilators globally, securing its position as the second-largest market shareholder.

A breakdown of the primary participants (supply-side) for the ventilators market referred to for this report is provided below:

  • By Company Type: Tier 1-25%, Tier 2-40%, and Tier 3-35%
  • By Designation: C-level-20%, Director Level-38%, and Others-40%
  • By Region: North America-37%, Europe-28%, Asia Pacific-26%, Latin America- 6%, and Middle East and Africa- 1% and GCC Countries- 2%

Prominent players in this market include Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), ResMed (US), Nihon Kohden Corporation (Japan), ZOLL Medical Corporation (US), Getinge AB (Sweden), Dragerwerk AG & Co. KGaA (Germany), ICU Medical, Inc. (US), Hamilton Medical (Switzerland), Lowenstein Medical SE & Co. KG (Germany), Fisher & Paykel Healthcare Limited (New Zealand), Skanray Technologies Ltd. (India), aXcent Medical GmbH (Germany), Metran Co., Ltd. (Japan), MAGNAMED (Brazil), Leistung Ingenieria SRL (Argentina), Breas Medical AB (Sweden), Airon Corporation (US), TRITON Electronic Systems Ltd. (Russia), Bio-Med Devices, Inc. (US), HEYER Medical AG (Germany), AgVa Healthcare (India), Biodesign Innovation Labs (India), NOCCARC Robotics Pvt. Ltd. (India), Umbulizer (India), Schiller Healthcare India Pvt. Ltd. (India), and AVI Healthcare (India).

Research Coverage:

The market study covers the ventilators market across various segments. It aims to estimate the market size and growth potential of this market across different segments by mobility, type, age group, interface, mode, care setting, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

  • Analysis of Market Dynamics: Drivers (Rise in respiratory diseases (Urbanization and rising pollution levels, Rising obesity due to sedentary lifestyles, Growing geriatric population worldwide, Increasing preference for home care settings, Rising number of preterm births, Outbreak of infectious respiratory diseases)), restraints (Shortage of skilled medical workers, Excessive purchase of ventilators during COVID-19, Reimbursement concerns), opportunities (Cost-efficiency of home care services, Growth opportunities in emerging economies), and challenges (Low awareness and inadequate resources in emerging economies, Harmful effects of respiratory devices on neonates, Supply chain disruptions, Global demand fluctuations).
  • Services/Innovations: Detailed insights on upcoming technologies, research & development activities, and new product launches in the ventilators market.
  • Market Development: Comprehensive information on the lucrative emerging markets, components, demographics, care settings, and regions.
  • Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the ventilators market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the ventilators market like ResMed (US), Getinge AB (Sweden), Koninklijke Philips N.V. (Netherlands), Dragerwerk AG & CO. KGAA (Germany), and ICU Medical, Inc. (US).
Show more
Product Code: MD 4529

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED & REGIONS CONSIDERED
    • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.4 YEARS CONSIDERED
  • 1.5 CURRENCY USED
  • 1.6 STAKEHOLDERS
  • 1.7 LIMITATIONS
  • 1.8 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

  • 2.1 KEY INSIGHTS & MARKET HIGHLIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH
  • 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
  • 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 VENTILATORS MARKET OVERVIEW
  • 3.2 ASIA PACIFIC: VENTILATORS MARKET, BY MOBILITY AND COUNTRY (2025)
  • 3.3 VENTILATORS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 3.4 VENTILATORS MARKET: REGIONAL MIX
  • 3.5 VENTILATORS MARKET: DEVELOPED VS. EMERGING ECONOMIES

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Rise in respiratory diseases
        • 4.2.1.1.1 Increasing incidence of COPD and asthma
        • 4.2.1.1.2 Growing tobacco consumption
      • 4.2.1.2 Urbanization and rising pollution levels
      • 4.2.1.3 Rising obesity due to sedentary lifestyles
      • 4.2.1.4 Growing geriatric population worldwide
      • 4.2.1.5 Increasing preference for home care settings
      • 4.2.1.6 Rising number of preterm births
      • 4.2.1.7 Outbreak of infectious respiratory diseases
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 Shortage of skilled medical workers
      • 4.2.2.2 Excessive purchase of ventilators during COVID-19
      • 4.2.2.3 Reimbursement concerns
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 Cost-efficiency of home care services
      • 4.2.3.2 Growth opportunities in emerging economies
    • 4.2.4 CHALLENGES
      • 4.2.4.1 Low awareness and inadequate resources in emerging economies
      • 4.2.4.2 Harmful effects of respiratory devices on neonates
      • 4.2.4.3 Supply chain disruptions
      • 4.2.4.4 Global demand fluctuations
  • 4.3 UNMET NEEDS & WHITE SPACES
    • 4.3.1 UNMET NEEDS IN VENTILATORS MARKET
    • 4.3.2 WHITE SPACE OPPORTUNITIES
  • 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
    • 4.4.1 INTERCONNECTED MARKETS
    • 4.4.2 CROSS-SECTOR OPPORTUNITIES
  • 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

  • 5.1 PORTER'S FIVE FORCES ANALYSIS
    • 5.1.1 THREAT OF NEW ENTRANTS
    • 5.1.2 THREAT OF SUBSTITUTES
    • 5.1.3 BARGAINING POWER OF SUPPLIERS
    • 5.1.4 BARGAINING POWER OF BUYERS
    • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.2 MACROECONOMIC OUTLOOK
    • 5.2.1 INTRODUCTION
    • 5.2.2 GDP TRENDS & FORECAST
    • 5.2.3 TRENDS IN GLOBAL VENTILATORS INDUSTRY
    • 5.2.4 TRENDS IN GLOBAL HEALTHCARE & CRITICAL CARE INDUSTRY
  • 5.3 SUPPLY CHAIN ANALYSIS
  • 5.4 VALUE CHAIN ANALYSIS
  • 5.5 ECOSYSTEM ANALYSIS
  • 5.6 PRICING ANALYSIS
    • 5.6.1 INDICATIVE PRICING OF VENTILATORS, BY KEY PLAYER, 2025
    • 5.6.2 AVERAGE SELLING PRICE TREND OF VENTILATORS, BY REGION, 2023-2025
  • 5.7 TRADE ANALYSIS
    • 5.7.1 IMPORT SCENARIO (HS CODE 9018)
    • 5.7.2 EXPORT DATA (HS CODE 9018)
  • 5.8 KEY CONFERENCES & EVENTS, 2026-2027
  • 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.10 INVESTMENT & FUNDING SCENARIO
  • 5.11 CASE STUDY ANALYSIS
    • 5.11.1 CASE STUDY 1: SCALING AI-ENABLED CRITICAL CARE VENTILATION
    • 5.11.2 CASE STUDY2: EXPANDING HOME RESPIRATORY CARE THROUGH CONNECTED VENTILATION
    • 5.11.3 CASE STUDY 3: ENHANCING ICU RESPIRATORY CARE WITH INTEGRATED VENTILATION
  • 5.12 IMPACT OF 2025 US TARIFFS ON VENTILATORS MARKET
    • 5.12.1 INTRODUCTION
    • 5.12.2 KEY TARIFF RATES
    • 5.12.3 PRICE IMPACT ANALYSIS
    • 5.12.4 IMPACT ON COUNTRIES/REGIONS
      • 5.12.4.1 North America
      • 5.12.4.2 Europe
      • 5.12.4.3 Asia Pacific
    • 5.12.5 END-USE INDUSTRY IMPACT

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

  • 6.1 KEY EMERGING TECHNOLOGIES
    • 6.1.1 INTELLIGENT & CLOSED-LOOP VENTILATION SYSTEMS
  • 6.2 COMPLEMENTARY TECHNOLOGIES
    • 6.2.1 REMOTE MONITORING SYSTEMS
  • 6.3 TECHNOLOGY/PRODUCT ROADMAP
    • 6.3.1 SHORT-TERM (2025-2027) | FOUNDATION & EARLY COMMERCIALIZATION
    • 6.3.2 1.16.2 MID-TERM (2027-2030) | EXPANSION & STANDARDIZATION
    • 6.3.3 1.16.3 LONG-TERM (2030-2035+) | MASS COMMERCIALIZATION & DISRUPTION
  • 6.4 PATENT ANALYSIS
    • 6.4.1 INSIGHTS: JURISDICTION & TOP APPLICANT ANALYSIS
  • 6.5 FUTURE APPLICATIONS
    • 6.5.1 AI-ENABLED REMOTE VENTILATION MANAGEMENT & PREDICTIVE CARE
    • 6.5.2 SMART RESPIRATORY CARE ECOSYSTEMS
    • 6.5.3 ADVANCED VENTILATOR CONSUMABLES & LUNG-PROTECTIVE SOLUTIONS
  • 6.6 IMPACT OF AI/GEN AI ON VENTILATORS MARKET
    • 6.6.1 TOP USE CASES & MARKET POTENTIAL
    • 6.6.2 CASE STUDIES OF AI IMPLEMENTATION IN VENTILATORS MARKET
    • 6.6.3 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS
    • 6.6.4 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN VENTILATORS MARKET

7 REGULATORY LANDSCAPE

  • 7.1 REGIONAL REGULATIONS & COMPLIANCE
    • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 7.1.2 INDUSTRY STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

  • 8.1 DECISION-MAKING PROCESS
  • 8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
    • 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 8.2.2 BUYING CRITERIA
  • 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
  • 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
  • 8.5 MARKET PROFITABILITY
    • 8.5.1 REVENUE POTENTIAL
    • 8.5.2 COST DYNAMICS
    • 8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS

9 VENTILATORS MARKET, BY MOBILITY

  • 9.1 INTRODUCTION
  • 9.2 INTENSIVE CARE VENTILATORS
    • 9.2.1 HIGH-END ICU VENTILATORS
      • 9.2.1.1 Rising healthcare expenditure and improving infrastructure in emerging economies to drive market
    • 9.2.2 MID-END ICU VENTILATORS
      • 9.2.2.1 Higher affordability and accessibility to drive market
    • 9.2.3 BASIC ICU VENTILATORS
      • 9.2.3.1 Growing use in ambulatory care centers to drive market
  • 9.3 PORTABLE/TRANSPORTABLE VENTILATORS
    • 9.3.1 INCREASING DEMAND FOR COMPACT DEVICES FOR MECHANICAL VENTILATION TO DRIVE MARKET

10 VENTILATORS MARKET, BY TYPE

  • 10.1 INTRODUCTION
  • 10.2 ADULT & PEDIATRIC VENTILATORS
    • 10.2.1 GROWING GERIATRIC POPULATION TO DRIVE MARKET
  • 10.3 NEONATAL & INFANT VENTILATORS
    • 10.3.1 TECHNOLOGICAL ADVANCEMENTS IN NEONATAL MONITORS TO DRIVE MARKET

11 VENTILATORS MARKET, BY INTERFACE

  • 11.1 INTRODUCTION
  • 11.2 DUAL-CAPABILITY VENTILATION
    • 11.2.1 RISING PREVALENCE OF COPD & ARDS TO DRIVE MARKET GROWTH
  • 11.3 NON-INVASIVE VENTILATION
    • 11.3.1 RELIABILITY OF MECHANICAL DESIGNS TO SUPPORT MARKET GROWTH
  • 11.4 INVASIVE VENTILATION
    • 11.4.1 RISING PREVALENCE OF RESPIRATORY DISEASES TO DRIVE MARKET

12 VENTILATORS MARKET, BY MODE

  • 12.1 INTRODUCTION
  • 12.2 COMBINED-MODE VENTILATORS
    • 12.2.1 COMBINED BENEFITS OF VOLUME-TARGETED AND PRESSURE-TARGETED VENTILATORS TO DRIVE MARKET
  • 12.3 VOLUME-MODE VENTILATORS
    • 12.3.1 INCREASING DEMAND FOR ADVANCED RESPIRATORY SUPPORT SYSTEMS IN HEALTHCARE SETTINGS TO DRIVE MARKET
  • 12.4 PRESSURE-MODE VENTILATORS
    • 12.4.1 PRESET INSPIRATORY PRESSURE MAINTENANCE AND BETTER PATIENT COMFORT TO DRIVE MARKET
  • 12.5 OTHER VENTILATOR MODES

13 VENTILATORS MARKET, BY CARE SETTING

  • 13.1 INTRODUCTION
  • 13.2 HOSPITALS & CLINICS
    • 13.2.1 RISING DEMAND FOR VENTILATORS IN PRIVATE HOSPITALS TO DRIVE MARKET
  • 13.3 AMBULATORY CARE CENTERS
    • 13.3.1 INCREASING NUMBER OF OUTPATIENT VISITS TO DRIVE MARKET
  • 13.4 EMERGENCY MEDICAL SERVICES
    • 13.4.1 HIGH INCIDENCE OF TRAUMA INJURIES TO DRIVE MARKET
  • 13.5 HOME CARE SETTINGS
    • 13.5.1 EMERGENCE OF REMOTE PATIENT MONITORING DEVICES TO DRIVE MARKET

14 VENTILATORS MARKET, BY REGION

  • 14.1 INTRODUCTION
  • 14.2 NORTH AMERICA
    • 14.2.1 US
      • 14.2.1.1 High prevalence of COPD to drive the market
    • 14.2.2 CANADA
      • 14.2.2.1 Increasing incidence of asthma to drive market growth
  • 14.3 EUROPE
    • 14.3.1 GERMANY
      • 14.3.1.1 Rising healthcare spending to increase demand for high-end ventilators
    • 14.3.2 FRANCE
      • 14.3.2.1 Highly advanced healthcare system to drive adoption of ventilators in hospitals
    • 14.3.3 UK
      • 14.3.3.1 Increasing healthcare expenditure to drive market growth
    • 14.3.4 ITALY
      • 14.3.4.1 High growth in geriatric population and subsequent rise in age-related respiratory diseases to drive market
    • 14.3.5 SPAIN
      • 14.3.5.1 High burden on state-run health insurance system and poor healthcare infrastructure to restrain market growth
    • 14.3.6 NETHERLANDS
      • 14.3.6.1 Rising prevalence of respiratory diseases to drive market
    • 14.3.7 REST OF EUROPE
  • 14.4 ASIA PACIFIC
    • 14.4.1 JAPAN
      • 14.4.1.1 Established healthcare system to increase adoption of respiratory care devices
    • 14.4.2 CHINA
      • 14.4.2.1 High prevalence of COPD and lung cancer to propel demand
    • 14.4.3 INDIA
      • 14.4.3.1 Rising focus of global players on Indian market to drive adoption of advanced ventilators
    • 14.4.4 AUSTRALIA
      • 14.4.4.1 High prevalence of chronic lung diseases to drive demand for ventilators
    • 14.4.5 REST OF ASIA PACIFIC
  • 14.5 LATIN AMERICA
    • 14.5.1 BRAZIL
      • 14.5.1.1 Healthcare infrastructure improvement to support market growth
    • 14.5.2 MEXICO
      • 14.5.2.1 Rising obesity rate to increase incidence of respiratory diseases
    • 14.5.3 ARGENTINA
      • 14.5.3.1 Incidence of severe acute respiratory infections to drive market
    • 14.5.4 REST OF LATIN AMERICA
  • 14.6 MIDDLE EAST & AFRICA
    • 14.6.1 RISING HEALTHCARE SPENDING AND PRESENCE OF MEDICAL DEVICE MANUFACTURING COMPANIES TO DRIVE MARKET
  • 14.7 GCC COUNTRIES
    • 14.7.1 HIGHER DISPOSABLE INCOME AND INCREASED GOVERNMENT HEALTHCARE EXPENDITURE TO PROPEL MARKET GROWTH

15 COMPETITIVE LANDSCAPE

  • 15.1 OVERVIEW
    • 15.1.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN VENTILATORS MARKET
  • 15.2 REVENUE ANALYSIS, 2021-2025
  • 15.3 MARKET SHARE ANALYSIS, 2025
  • 15.4 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
    • 15.4.1 STARS
    • 15.4.2 EMERGING LEADERS
    • 15.4.3 PERVASIVE PLAYERS
    • 15.4.4 PARTICIPANTS
    • 15.4.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
      • 15.4.5.1 Company footprint
      • 15.4.5.2 Company footprint
      • 15.4.5.3 Mobility footprint
      • 15.4.5.4 Type footprint
      • 15.4.5.5 Interface footprint
      • 15.4.5.6 Mode footprint
  • 15.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
    • 15.5.1 PROGRESSIVE COMPANIES
    • 15.5.2 RESPONSIVE COMPANIES
    • 15.5.3 DYNAMIC COMPANIES
    • 15.5.4 STARTING BLOCKS
    • 15.5.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
      • 15.5.5.1 Detailed list of key startups/SMEs
      • 15.5.5.2 Competitive benchmarking of key startups/SMEs
  • 15.6 R&D EXPENDITURE
  • 15.7 COMPANY VALUATION & FINANCIAL METRICS
    • 15.7.1 FINANCIAL METRICS
    • 15.7.2 COMPANY VALUATION
  • 15.8 BRAND/PRODUCT COMPARISON
  • 15.9 COMPETITIVE SCENARIO
    • 15.9.1 PRODUCT LAUNCHES
    • 15.9.2 DEALS
    • 15.9.3 OTHER DEVELOPMENTS

16 COMPANY PROFILES

  • 16.1 KEY PLAYERS
    • 16.1.1 DRAGERWERK AG & CO. KGAA
      • 16.1.1.1 Business overview
      • 16.1.1.2 Products offered
      • 16.1.1.3 Recent developments
        • 16.1.1.3.1 Product launches
        • 16.1.1.3.2 Deals
        • 16.1.1.3.3 Other developments
      • 16.1.1.4 MnM view
        • 16.1.1.4.1 Key strengths
        • 16.1.1.4.2 Strategic choices
        • 16.1.1.4.3 Weaknesses & competitive threats
    • 16.1.2 GETINGE AB
      • 16.1.2.1 Business overview
      • 16.1.2.2 Products offered
      • 16.1.2.3 Recent developments
        • 16.1.2.3.1 Product launches
        • 16.1.2.3.2 Deals
        • 16.1.2.3.3 Other developments
      • 16.1.2.4 MnM view
        • 16.1.2.4.1 Key strengths
        • 16.1.2.4.2 Strategic choices
        • 16.1.2.4.3 Weaknesses & competitive threats
    • 16.1.3 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
      • 16.1.3.1 Business overview
      • 16.1.3.2 Products offered
      • 16.1.3.3 Recent developments
        • 16.1.3.3.1 Product launches
        • 16.1.3.3.2 Other developments
      • 16.1.3.4 MnM view
        • 16.1.3.4.1 Key strengths
        • 16.1.3.4.2 Strategic choices
        • 16.1.3.4.3 Weaknesses & competitive threats
    • 16.1.4 ASAHI KASEI CORPORATION
      • 16.1.4.1 Business overview
      • 16.1.4.2 Products offered
      • 16.1.4.3 Recent developments
        • 16.1.4.3.1 Deals
    • 16.1.5 RESMED INC.
      • 16.1.5.1 Business overview
      • 16.1.5.2 Products offered
      • 16.1.5.3 Recent developments
        • 16.1.5.3.1 Product launches
        • 16.1.5.3.2 Deals
        • 16.1.5.3.3 Other developments
      • 16.1.5.4 MnM view
        • 16.1.5.4.1 Key strengths
        • 16.1.5.4.2 Strategic choices
        • 16.1.5.4.3 Weaknesses & competitive threats
    • 16.1.6 KONINKLIJKE PHILIPS N.V.
      • 16.1.6.1 Business overview
      • 16.1.6.2 Products offered
      • 16.1.6.3 Recent developments
        • 16.1.6.3.1 Other developments
      • 16.1.6.4 MnM view
        • 16.1.6.4.1 Key strengths
        • 16.1.6.4.2 Strategic choices
        • 16.1.6.4.3 Weaknesses & competitive threats
    • 16.1.7 ICU MEDICAL INC.
      • 16.1.7.1 Business overview
      • 16.1.7.2 Products offered
      • 16.1.7.3 Recent developments
        • 16.1.7.3.1 Deals
      • 16.1.7.4 MnM view
        • 16.1.7.4.1 Key strengths
        • 16.1.7.4.2 Strategic choices
        • 16.1.7.4.3 Weaknesses & competitive threats
    • 16.1.8 AIR LIQUIDE
      • 16.1.8.1 Business overview
      • 16.1.8.2 Products offered
      • 16.1.8.3 MnM view
        • 16.1.8.3.1 Key strengths
        • 16.1.8.3.2 Strategic choices
        • 16.1.8.3.3 Weaknesses & competitive threats
    • 16.1.9 FLEXICARE (GROUP) LIMITED
      • 16.1.9.1 Business overview
      • 16.1.9.2 Products offered
      • 16.1.9.3 Recent developments
        • 16.1.9.3.1 Deals
    • 16.1.10 NIHON KOHDEN CORPORATION
      • 16.1.10.1 Business overview
      • 16.1.10.2 Products offered
      • 16.1.10.3 Recent developments
        • 16.1.10.3.1 Product launches
      • 16.1.10.4 MnM view
        • 16.1.10.4.1 Key strengths
        • 16.1.10.4.2 Strategic choices
        • 16.1.10.4.3 Weaknesses & competitive threats
    • 16.1.11 GE HEALTHCARE
      • 16.1.11.1 Business overview
      • 16.1.11.2 Products offered
      • 16.1.11.3 MnM view
        • 16.1.11.3.1 Key strengths
        • 16.1.11.3.2 Strategic choices
        • 16.1.11.3.3 Weaknesses & competitive threats
    • 16.1.12 HAMILTON MEDICAL
      • 16.1.12.1 Business overview
      • 16.1.12.2 Products offered
      • 16.1.12.3 Recent developments
        • 16.1.12.3.1 Product upgrades
        • 16.1.12.3.2 Deals
        • 16.1.12.3.3 Other developments
      • 16.1.12.4 MnM view
        • 16.1.12.4.1 Key strengths
        • 16.1.12.4.2 Strategic choices
        • 16.1.12.4.3 Weaknesses & competitive threats
    • 16.1.13 LOWENSTEIN MEDICAL TECHNOLOGY GMBH & CO. KG
      • 16.1.13.1 Business overview
      • 16.1.13.2 Products offered
      • 16.1.13.3 MnM view
        • 16.1.13.3.1 Key strengths
        • 16.1.13.3.2 Strategic choices
        • 16.1.13.3.3 Weaknesses & competitive threats
  • 16.2 OTHER PLAYERS
    • 16.2.1 SKANRAY TECHNOLOGIES, LTD.
    • 16.2.2 METRAN CO., LTD.
    • 16.2.3 MAGNAMED
    • 16.2.4 LEISTUNG INGENIERIA SRL
    • 16.2.5 AIRON CORPORATION
    • 16.2.6 TRITON ELECTRONIC SYSTEMS LTD.
    • 16.2.7 BIO-MED DEVICES, INC.
    • 16.2.8 HEYER MEDICAL AG
    • 16.2.9 AGVA HEALTHCARE
    • 16.2.10 SCHILLER AG
    • 16.2.11 AVI HEALTHCARE LIMITED
    • 16.2.12 MAGNAMEDIA B.V.
    • 16.2.13 BREAS MEDICAL AB
    • 16.2.14 BEIJING AEONMED CO., LTD
    • 16.2.15 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD
    • 16.2.16 REACT HEALTH
    • 16.2.17 MICOMME MEDICAL TECHNOLOGY DEVELOPMENT CO., LTD
    • 16.2.18 CHIRANA MEDICAL, A.S.

17 RESEARCH METHODOLOGY

  • 17.1 RESEARCH DATA
    • 17.1.1 SECONDARY RESEARCH
    • 17.1.2 PRIMARY RESEARCH
  • 17.2 MARKET SIZE ESTIMATION
  • 17.3 MARKET BREAKDOWN & DATA TRIANGULATION
  • 17.4 RESEARCH ASSUMPTIONS
  • 17.5 RESEARCH LIMITATIONS
    • 17.5.1 SCOPE-RELATED LIMITATIONS
    • 17.5.2 METHODOLOGY-RELATED LIMITATIONS
  • 17.6 RISK ASSESSMENT

18 APPENDIX

  • 18.1 DISCUSSION GUIDE
  • 18.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 18.3 CUSTOMIZATION OPTIONS
  • 18.4 RELATED REPORTS
  • 18.5 AUTHOR DETAILS
Show more
Product Code: MD 4529

List of Tables

  • TABLE 1 STANDARD CURRENCY CONVERSION RATES (USD)
  • TABLE 2 DISORDERS AND DEATHS CAUSED BY SMOKING, 2024
  • TABLE 3 VENTILATORS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 4 GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021-2030
  • TABLE 5 INDICATIVE PRICING OF VENTILATORS, BY KEY PLAYER, 2025 (USD)
  • TABLE 6 AVERAGE SELLING PRICE TREND OF HIGH-END VENTILATORS, BY REGION, 2023-2025 (USD)
  • TABLE 7 IMPORT DATA FOR VENTILATOR PRODUCTS UNDER HS CODE 9018, BY COUNTRY, 2021-2025 (USD THOUSAND)
  • TABLE 8 EXPORT DATA FOR VENTILATOR PRODUCTS UNDER HS CODE 9018, BY COUNTRY, 2021-2025 (USD THOUSAND)
  • TABLE 9 VENTILATORS MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS (2026-2027)
  • TABLE 10 US-ADJUSTED RECIPROCAL TARIFF RATES "RECIPROCAL TARIFF, ADJUSTED" FOR THE TOP 20 TRADE PARTNERS
  • TABLE 11 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR VENTILATORS
  • TABLE 12 VENTILATORS MARKET: CASE STUDIES RELATED TO AI IMPLEMENTATION
  • TABLE 13 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS
  • TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 GLOBAL STANDARDS IN VENTILATORS MARKET
  • TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VENTILATORS
  • TABLE 21 KEY BUYING CRITERIA FOR VENTILATORS
  • TABLE 22 VENTILATORS MARKET: UNMET NEEDS/END-USER EXPECTATIONS
  • TABLE 23 VENTILATORS MARKET, BY MOBILITY, 2024-2031 (USD MILLION)
  • TABLE 24 INTENSIVE CARE VENTILATORS: KEY PRODUCTS
  • TABLE 25 INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 26 INTENSIVE CARE VENTILATORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 27 INTENSIVE CARE VENTILATORS MARKET, BY REGION, 2024-2031 (THOUSAND UNITS)
  • TABLE 28 HIGH-END ICU VENTILATORS: KEY PRODUCTS
  • TABLE 29 HIGH-END ICU VENTILATORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 30 HIGH-END ICU VENTILATORS MARKET, BY REGION, 2024-2031 (THOUSAND UNITS)
  • TABLE 31 MID-END ICU VENTILATORS: KEY PRODUCTS
  • TABLE 32 MID-END ICU VENTILATORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 33 MID-END ICU VENTILATORS MARKET, BY REGION, 2024-2031 (THOUSAND UNITS)
  • TABLE 34 BASIC ICU VENTILATORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 35 BASIC ICU VENTILATORS MARKET, BY REGION, 2024-2031 (THOUSAND UNITS)
  • TABLE 36 PORTABLE/TRANSPORTABLE VENTILATORS: KEY PRODUCTS
  • TABLE 37 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 38 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY REGION, 2024-2031 (THOUSAND UNITS)
  • TABLE 39 VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 40 ADULT & PEDIATRIC VENTILATORS: KEY PRODUCTS
  • TABLE 41 ADULT & PEDIATRIC VENTILATORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 42 NEONATAL & INFANT VENTILATORS: KEY PRODUCTS
  • TABLE 43 NEONATAL & INFANT VENTILATORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 44 VENTILATORS MARKET, BY INTERFACE, 2024-2031 (USD MILLION)
  • TABLE 45 DUAL-CAPABILITY VENTILATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 46 NON-INVASIVE VENTILATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 47 INVASIVE VENTILATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 48 VENTILATORS MARKET, BY MODE, 2024-2031 (USD MILLION)
  • TABLE 49 COMBINED-MODE VENTILATORS: KEY PRODUCTS
  • TABLE 50 COMBINED-MODE VENTILATORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 51 VOLUME-MODE VENTILATORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 52 PRESSURE-MODE VENTILATORS: KEY PRODUCTS
  • TABLE 53 PRESSURE-MODE VENTILATORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 54 OTHER VENTILATOR MODES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 55 VENTILATORS MARKET, BY CARE SETTING, 2024-2031 (USD MILLION)
  • TABLE 56 VENTILATORS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 57 VENTILATORS MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 58 VENTILATORS MARKET FOR EMERGENCY MEDICAL SERVICES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 59 VENTILATORS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 60 VENTILATORS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 61 NORTH AMERICA: VENTILATORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 62 NORTH AMERICA: VENTILATORS MARKET, BY MOBILITY, 2024-2031 (USD MILLION)
  • TABLE 63 NORTH AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 64 NORTH AMERICA: VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 65 NORTH AMERICA: VENTILATORS MARKET, BY INTERFACE, 2024-2031 (USD MILLION)
  • TABLE 66 NORTH AMERICA: VENTILATORS MARKET, BY MODE, 2024-2031 (USD MILLION)
  • TABLE 67 NORTH AMERICA: VENTILATORS MARKET, BY CARE SETTING, 2024-2031 (USD MILLION)
  • TABLE 68 US: VENTILATORS MARKET, BY MOBILITY, 2024-2031 (USD MILLION)
  • TABLE 69 US: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 70 US: VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 71 US: VENTILATORS MARKET, BY INTERFACE, 2024-2031 (USD MILLION)
  • TABLE 72 US: VENTILATORS MARKET, BY MODE, 2024-2031 (USD MILLION)
  • TABLE 73 US: VENTILATORS MARKET, BY CARE SETTING, 2024-2031 (USD MILLION)
  • TABLE 74 CANADA: VENTILATORS MARKET, BY MOBILITY, 2024-2031 (USD MILLION)
  • TABLE 75 CANADA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 76 CANADA: VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 77 CANADA: VENTILATORS MARKET, BY INTERFACE, 2024-2031 (USD MILLION)
  • TABLE 78 CANADA: VENTILATORS MARKET, BY MODE, 2024-2031 (USD MILLION)
  • TABLE 79 CANADA: VENTILATORS MARKET, BY CARE SETTING, 2024-2031 (USD MILLION)
  • TABLE 80 EUROPE: VENTILATORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 81 EUROPE: VENTILATORS MARKET, BY MOBILITY, 2024-2031 (USD MILLION)
  • TABLE 82 EUROPE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 83 EUROPE: VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 84 EUROPE: VENTILATORS MARKET, BY INTERFACE, 2024-2031 (USD MILLION)
  • TABLE 85 EUROPE: VENTILATORS MARKET, BY MODE, 2024-2031 (USD MILLION)
  • TABLE 86 EUROPE: VENTILATORS MARKET, BY CARE SETTING, 2024-2031 (USD MILLION)
  • TABLE 87 GERMANY: VENTILATORS MARKET, BY MOBILITY, 2024-2031 (USD MILLION)
  • TABLE 88 GERMANY: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 89 GERMANY: VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 90 GERMANY: VENTILATORS MARKET, BY INTERFACE, 2024-2031 (USD MILLION)
  • TABLE 91 GERMANY: VENTILATORS MARKET, BY MODE, 2024-2031 (USD MILLION)
  • TABLE 92 GERMANY: VENTILATORS MARKET, BY CARE SETTING, 2024-2031 (USD MILLION)
  • TABLE 93 FRANCE: VENTILATORS MARKET, BY MOBILITY, 2024-2031 (USD MILLION)
  • TABLE 94 FRANCE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 95 FRANCE: VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 96 FRANCE: VENTILATORS MARKET, BY INTERFACE, 2024-2031 (USD MILLION)
  • TABLE 97 FRANCE: VENTILATORS MARKET, BY MODE, 2024-2031 (USD MILLION)
  • TABLE 98 FRANCE: VENTILATORS MARKET, BY CARE SETTING, 2024-2031 (USD MILLION)
  • TABLE 99 UK: VENTILATORS MARKET, BY MOBILITY, 2024-2031 (USD MILLION)
  • TABLE 100 UK: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 101 UK: VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 102 UK: VENTILATORS MARKET, BY INTERFACE, 2024-2031 (USD MILLION)
  • TABLE 103 UK: VENTILATORS MARKET, BY MODE, 2024-2031 (USD MILLION)
  • TABLE 104 UK: VENTILATORS MARKET, BY CARE SETTING, 2024-2031 (USD MILLION)
  • TABLE 105 ITALY: VENTILATORS MARKET, BY MOBILITY, 2024-2031 (USD MILLION)
  • TABLE 106 ITALY: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 107 ITALY: VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 108 ITALY: VENTILATORS MARKET, BY INTERFACE, 2024-2031 (USD MILLION)
  • TABLE 109 ITALY: VENTILATORS MARKET, BY MODE, 2024-2031 (USD MILLION)
  • TABLE 110 ITALY: VENTILATORS MARKET, BY CARE SETTING, 2024-2031 (USD MILLION)
  • TABLE 111 SPAIN: VENTILATORS MARKET, BY MOBILITY, 2024-2031 (USD MILLION)
  • TABLE 112 SPAIN: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 113 SPAIN: VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 114 SPAIN: VENTILATORS MARKET, BY INTERFACE, 2024-2031 (USD MILLION)
  • TABLE 115 SPAIN: VENTILATORS MARKET, BY MODE, 2024-2031 (USD MILLION)
  • TABLE 116 SPAIN: VENTILATORS MARKET, BY CARE SETTING, 2024-2031 (USD MILLION)
  • TABLE 117 NETHERLANDS: VENTILATORS MARKET, BY MOBILITY, 2024-2031 (USD MILLION)
  • TABLE 118 NETHERLANDS: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 119 NETHERLANDS: VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 120 NETHERLANDS: VENTILATORS MARKET, BY INTERFACE, 2024-2031 (USD MILLION)
  • TABLE 121 NETHERLANDS: VENTILATORS MARKET, BY MODE, 2024-2031 (USD MILLION)
  • TABLE 122 NETHERLANDS: VENTILATORS MARKET, BY CARE SETTING, 2024-2031 (USD MILLION)
  • TABLE 123 REST OF EUROPE: VENTILATORS MARKET, BY MOBILITY, 2024-2031 (USD MILLION)
  • TABLE 124 REST OF EUROPE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 125 REST OF EUROPE: VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 126 REST OF EUROPE: VENTILATORS MARKET, BY INTERFACE, 2024-2031 (USD MILLION)
  • TABLE 127 REST OF EUROPE: VENTILATORS MARKET, BY MODE, 2024-2031 (USD MILLION)
  • TABLE 128 REST OF EUROPE: VENTILATORS MARKET, BY CARE SETTING, 2024-2031 (USD MILLION)
  • TABLE 129 ASIA PACIFIC: VENTILATORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 130 ASIA PACIFIC: VENTILATORS MARKET, BY MOBILITY, 2024-2031 (USD MILLION)
  • TABLE 131 ASIA PACIFIC: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 132 ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 133 ASIA PACIFIC: VENTILATORS MARKET, BY INTERFACE, 2024-2031 (USD MILLION)
  • TABLE 134 ASIA PACIFIC: VENTILATORS MARKET, BY MODE, 2024-2031 (USD MILLION)
  • TABLE 135 ASIA PACIFIC: VENTILATORS MARKET, BY CARE SETTING, 2024-2031 (USD MILLION)
  • TABLE 136 JAPAN: VENTILATORS MARKET, BY MOBILITY, 2024-2031 (USD MILLION)
  • TABLE 137 JAPAN: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 138 JAPAN: VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 139 JAPAN: VENTILATORS MARKET, BY INTERFACE, 2024-2031 (USD MILLION)
  • TABLE 140 JAPAN: VENTILATORS MARKET, BY MODE, 2024-2031 (USD MILLION)
  • TABLE 141 JAPAN: VENTILATORS MARKET, BY CARE SETTING, 2024-2031 (USD MILLION)
  • TABLE 142 CHINA: VENTILATORS MARKET, BY MOBILITY, 2024-2031 (USD MILLION)
  • TABLE 143 CHINA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 144 CHINA: VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 145 CHINA: VENTILATORS MARKET, BY INTERFACE, 2024-2031 (USD MILLION)
  • TABLE 146 CHINA: VENTILATORS MARKET, BY MODE, 2024-2031 (USD MILLION).
  • TABLE 147 CHINA: VENTILATORS MARKET, BY CARE SETTING, 2024-2031 (USD MILLION)
  • TABLE 148 INDIA: VENTILATORS MARKET, BY MOBILITY, 2024-2031 (USD MILLION)
  • TABLE 149 INDIA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 150 INDIA: VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 151 INDIA: VENTILATORS MARKET, BY INTERFACE, 2024-2031 (USD MILLION)
  • TABLE 152 INDIA: VENTILATORS MARKET, BY MODE, 2024-2031 (USD MILLION)
  • TABLE 153 INDIA: VENTILATORS MARKET, BY CARE SETTING, 2024-2031 (USD MILLION)
  • TABLE 154 AUSTRALIA: VENTILATORS MARKET, BY MOBILITY, 2024-2031 (USD MILLION)
  • TABLE 155 AUSTRALIA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 156 AUSTRALIA: VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 157 AUSTRALIA: VENTILATORS MARKET, BY INTERFACE, 2024-2031 (USD MILLION)
  • TABLE 158 AUSTRALIA: VENTILATORS MARKET, BY MODE, 2024-2031 (USD MILLION)
  • TABLE 159 AUSTRALIA: VENTILATORS MARKET, BY CARE SETTING, 2024-2031 (USD MILLION)
  • TABLE 160 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY MOBILITY, 2024-2031 (USD MILLION)
  • TABLE 161 REST OF ASIA PACIFIC: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 162 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 163 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY INTERFACE, 2024-2031 (USD MILLION)
  • TABLE 164 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY MODE, 2024-2031 (USD MILLION)
  • TABLE 165 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY CARE SETTING, 2024-2031 (USD MILLION)
  • TABLE 166 LATIN AMERICA: VENTILATORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 167 LATIN AMERICA: VENTILATORS MARKET, BY MOBILITY, 2024-2031 (USD MILLION)
  • TABLE 168 LATIN AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 169 LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 170 LATIN AMERICA: VENTILATORS MARKET, BY INTERFACE, 2024-2031 (USD MILLION)
  • TABLE 171 LATIN AMERICA: VENTILATORS MARKET, BY MODE, 2024-2031 (USD MILLION)
  • TABLE 172 LATIN AMERICA: VENTILATORS MARKET, BY CARE SETTING, 2024-2031 (USD MILLION)
  • TABLE 173 BRAZIL: VENTILATORS MARKET, BY MOBILITY, 2024-2031 (USD MILLION)
  • TABLE 174 BRAZIL: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 175 BRAZIL: VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 176 BRAZIL: VENTILATORS MARKET, BY INTERFACE, 2024-2031 (USD MILLION)
  • TABLE 177 BRAZIL: VENTILATORS MARKET, BY MODE, 2024-2031 (USD MILLION)
  • TABLE 178 BRAZIL: VENTILATORS MARKET, BY CARE SETTING, 2024-2031 (USD MILLION)
  • TABLE 179 MEXICO: VENTILATORS MARKET, BY MOBILITY, 2024-2031 (USD MILLION)
  • TABLE 180 MEXICO: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 181 MEXICO: VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 182 MEXICO: VENTILATORS MARKET, BY INTERFACE, 2024-2031 (USD MILLION)
  • TABLE 183 MEXICO: VENTILATORS MARKET, BY MODE, 2024-2031 (USD MILLION)
  • TABLE 184 MEXICO: VENTILATORS MARKET, BY CARE SETTING, 2024-2031 (USD MILLION)
  • TABLE 185 ARGENTINA: VENTILATORS MARKET, BY MOBILITY, 2024-2031 (USD MILLION)
  • TABLE 186 ARGENTINA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 187 ARGENTINA: VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 188 ARGENTINA: VENTILATORS MARKET, BY INTERFACE, 2024-2031 (USD MILLION)
  • TABLE 189 ARGENTINA: VENTILATORS MARKET, BY MODE, 2024-2031 (USD MILLION)
  • TABLE 190 ARGENTINA: VENTILATORS MARKET, BY CARE SETTING, 2024-2031 (USD MILLION)
  • TABLE 191 REST OF LATIN AMERICA: VENTILATORS MARKET, BY MOBILITY, 2024-2031 (USD MILLION)
  • TABLE 192 REST OF LATIN AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 193 REST OF LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 194 REST OF LATIN AMERICA: VENTILATORS MARKET, BY INTERFACE, 2024-2031 (USD MILLION)
  • TABLE 195 REST OF LATIN AMERICA: VENTILATORS MARKET, BY MODE, 2024-2031 (USD MILLION)
  • TABLE 196 REST OF LATIN AMERICA: VENTILATORS MARKET, BY CARE SETTING, 2024-2031 (USD MILLION)
  • TABLE 197 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY MOBILITY, 2024-2031 (USD MILLION)
  • TABLE 198 MIDDLE EAST & AFRICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 199 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 200 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY INTERFACE, 2024-2031 (USD MILLION)
  • TABLE 201 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY MODE, 2024-2031 (USD MILLION)
  • TABLE 202 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY CARE SETTING, 2024-2031 (USD MILLION)
  • TABLE 203 GCC COUNTRIES: VENTILATORS MARKET, BY MOBILITY, 2024-2031 (USD MILLION)
  • TABLE 204 GCC COUNTRIES: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 205 GCC COUNTRIES: VENTILATORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 206 GCC COUNTRIES: VENTILATORS MARKET, BY INTERFACE, 2024-2031 (USD MILLION)
  • TABLE 207 GCC COUNTRIES: VENTILATORS MARKET, BY MODE, 2024-2031 (USD MILLION)
  • TABLE 208 GCC COUNTRIES: VENTILATORS MARKET, BY CARE SETTING, 2024-2031 (USD MILLION)
  • TABLE 209 VENTILATORS MARKET: DEGREE OF COMPETITION
  • TABLE 210 VENTILATORS MARKET: REGION FOOTPRINT
  • TABLE 211 VENTILATORS MARKET: MOBILITY FOOTPRINT
  • TABLE 212 VENTILATORS MARKET: TYPE FOOTPRINT
  • TABLE 213 VENTILATORS MARKET: INTERFACE FOOTPRINT
  • TABLE 214 VENTILATORS MARKET: MODE FOOTPRINT
  • TABLE 215 VENTILATORS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 216 VENTILATOR MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 217 VENTILATORS MARKET: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2026
  • TABLE 218 VENTILATORS MARKET: DEALS, JANUARY 2021-JUNE 2026
  • TABLE 219 VENTILATORS MARKET: OTHER DEVELOPMENTS, JANUARY 2021-JUNE 2026
  • TABLE 220 DRAGERWERK AG & CO. KGAA: COMPANY OVERVIEW
  • TABLE 221 DRAGERWERK AG & CO. KGAA: PRODUCTS OFFERED
  • TABLE 222 DRAGERWERK AG & CO. KGAA: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2026
  • TABLE 223 DRAGERWERK AG & CO. KGAA: DEALS, JANUARY 2021-JUNE 2026
  • TABLE 224 DRAGERWERK AG & CO. KGAA: OTHER DEVELOPMENTS, JANUARY 2021-JUNE 2026
  • TABLE 225 GETINGE AB: COMPANY OVERVIEW
  • TABLE 226 GETINGE AB: PRODUCTS OFFERED
  • TABLE 227 GETINGE AB: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2026
  • TABLE 228 GETINGE AB: DEALS, JANUARY 2021-JUNE 2026
  • TABLE 229 GETINGE AB: OTHER DEVELOPMENTS, JANUARY 2021-JUNE 2026
  • TABLE 230 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW
  • TABLE 231 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED
  • TABLE 232 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2026
  • TABLE 233 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2021-JUNE 2026
  • TABLE 234 ASAHI KASEI CORPORATION: COMPANY OVERVIEW
  • TABLE 235 ASAHI KASEI CORPORATION: PRODUCTS OFFERED
  • TABLE 236 ASAHI KASEI CORPORATION: DEALS, JANUARY 2021-JUNE 2026
  • TABLE 237 RESMED INC.: COMPANY OVERVIEW
  • TABLE 238 RESMED INC.: PRODUCTS OFFERED
  • TABLE 239 RESMED INC.: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2026
  • TABLE 240 RESMED INC.: DEALS, JANUARY 2021-JUNE 2026
  • TABLE 241 RESMED INC.: OTHER DEVELOPMENTS, JANUARY 2021-JUNE 2026
  • TABLE 242 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
  • TABLE 243 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
  • TABLE 244 KONINKLIJKE PHILIPS N.V.: OTHER DEVELOPMENTS, JANUARY 2021-JUNE 2026
  • TABLE 245 ICU MEDICAL INC.: COMPANY OVERVIEW
  • TABLE 246 ICU MEDICAL INC.: PRODUCTS OFFERED
  • TABLE 247 ICU MEDICAL INC.: DEALS, JANUARY 2021-JUNE 2026
  • TABLE 248 AIR LIQUIDE: COMPANY OVERVIEW
  • TABLE 249 AIR LIQUIDE: PRODUCTS OFFERED
  • TABLE 250 FLEXICARE (GROUP) LIMITED: COMPANY OVERVIEW
  • TABLE 251 FLEXICARE (GROUP) LIMITED: PRODUCTS OFFERED
  • TABLE 252 FLEXICARE (GROUP) LIMITED: DEALS, JANUARY 2021-JUNE 2026
  • TABLE 253 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
  • TABLE 254 NIHON KOHDEN CORPORATION: PRODUCTS OFFERED
  • TABLE 255 NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2026
  • TABLE 256 GE HEALTHCARE: COMPANY OVERVIEW
  • TABLE 257 GE HEALTHCARE: PRODUCTS OFFERED
  • TABLE 258 HAMILTON MEDICAL: COMPANY OVERVIEW
  • TABLE 259 HAMILTON MEDICAL: PRODUCTS OFFERED
  • TABLE 260 HAMILTON MEDICAL: PRODUCT UPGRADES, JANUARY 2021-JUNE 2026
  • TABLE 261 HAMILTON MEDICAL: DEALS, JANUARY 2021-JUNE 2026
  • TABLE 262 HAMILTON MEDICAL: OTHER DEVELOPMENTS, JANUARY 2021-JUNE 2026
  • TABLE 263 RISK ASSESSMENT

List of Figures

  • FIGURE 1 VENTILATORS MARKET SEGMENTATION & REGIONS COVERED
  • FIGURE 2 KEY INSIGHTS & MARKET HIGHLIGHTS
  • FIGURE 3 VENTILATORS MARKET, 2024-2031
  • FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN VENTILATORS MARKET
  • FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF VENTILATORS MARKET
  • FIGURE 6 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN VENTILATORS MARKET, 2026
  • FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 8 RISING PREVALENCE OF CHRONIC RESPIRATORY DISEASES TO DRIVE MARKET
  • FIGURE 9 INTENSIVE CARE VENTILATORS SEGMENT ACCOUNTED FOR LARGEST SHARE IN 2025
  • FIGURE 10 INDIA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 11 NORTH AMERICA WILL DOMINATE MARKET TILL 2031
  • FIGURE 12 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES OVER FORECAST PERIOD
  • FIGURE 13 VENTILATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 14 ANNUAL DEATHS CAUSED BY HOUSEHOLD AND AMBIENT AIR POLLUTION, BY DISEASE TYPE, 2024
  • FIGURE 15 GLOBAL GERIATRIC POPULATION, BY COUNTRY, 2015 VS. 2020 VS. 2023
  • FIGURE 16 VENTILATORS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 17 VENTILATORS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 18 VENTILATORS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 19 VENTILATORS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 20 AVERAGE SELLING PRICE TREND OF HIGH-END VENTILATORS, BY REGION, 2023-2025 (USD)
  • FIGURE 21 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 22 VENTILATORS MARKET: INVESTMENT & FUNDING SCENARIO
  • FIGURE 23 NUMBER OF PATENTS PUBLISHED (JANUARY 2016-JULY 2026)
  • FIGURE 24 TOP APPLICANT COUNTRIES/REGIONS FOR VENTILATORS (JANUARY 2016- JULY 2026)
  • FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VENTILATORS
  • FIGURE 26 KEY BUYING CRITERIA FOR VENTILATORS
  • FIGURE 27 NORTH AMERICA: VENTILATORS MARKET SNAPSHOT
  • FIGURE 28 ASIA PACIFIC: VENTILATORS MARKET SNAPSHOT
  • FIGURE 29 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES
  • FIGURE 30 REVENUE ANALYSIS OF KEY PLAYERS OPERATING IN VENTILATORS MARKET, 2021-2025
  • FIGURE 31 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VENTILATORS MARKET, 2025
  • FIGURE 32 VENTILATORS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
  • FIGURE 33 VENTILATORS MARKET: COMPANY FOOTPRINT
  • FIGURE 34 VENTILATORS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
  • FIGURE 35 R&D EXPENDITURE OF KEY PLAYERS IN VENTILATORS MARKET (2024 VS. 2025)
  • FIGURE 36 EV/EBITDA OF KEY VENDORS
  • FIGURE 37 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 38 BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 39 DRAGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2025)
  • FIGURE 40 GETINGE AB: COMPANY SNAPSHOT (2025)
  • FIGURE 41 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2025)
  • FIGURE 42 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2025)
  • FIGURE 43 RESMED INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 44 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2025)
  • FIGURE 45 SMITHS GROUP PLC: COMPANY SNAPSHOT (2025)
  • FIGURE 46 AIR LIQUIDE: COMPANY SNAPSHOT (2025)
  • FIGURE 47 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2025)
  • FIGURE 48 GE HEALTHCARE: COMPANY SNAPSHOT (2025)
  • FIGURE 49 RESEARCH DESIGN
  • FIGURE 50 KEY DATA FROM SECONDARY SOURCES
  • FIGURE 51 PRIMARY SOURCES
  • FIGURE 52 KEY DATA FROM PRIMARY SOURCES
  • FIGURE 53 KEY INDUSTRY INSIGHTS
  • FIGURE 54 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE & DEMAND-SIDE PARTICIPANTS
  • FIGURE 55 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 56 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY CARE SETTING, DESIGNATION, AND REGION
  • FIGURE 57 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 58 REVENUE SHARE ANALYSIS ILLUSTRATION: DRAGERWERK AG & CO. KGAA (GERMANY) (2025)
  • FIGURE 59 SUPPLY-SIDE MARKET SIZE ESTIMATION
  • FIGURE 60 DEMAND-SIDE MARKET SIZE ESTIMATION
  • FIGURE 61 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR VENTILATORS MARKET (2026-2031)
  • FIGURE 62 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 63 TOP-DOWN APPROACH
  • FIGURE 64 DATA TRIANGULATION METHODOLOGY
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!